We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Blood Sugar Levels Affect Risks in Type 1 Diabetes

By LabMedica International staff writers
Posted on 11 Sep 2019
Type 1 diabetes is the predominant form of diabetes diagnosed in childhood and is characterized by increased blood glucose levels resulting from insulin deficiency. More...
Intensive treatment with better glycemic control has been shown to reduce the risk of retinopathy and nephropathy, with a strong association between glycated hemoglobin (HbA1c) level and diabetes complications.

The evidence for HbA1c levels and diabetes complications is interpreted differently by organizations. Reaching lower HbA1c levels requires greater effort from people with diabetes and their families and can be associated with more stress and possibly an increased risk of hypoglycemia, which in itself can be burdensome and lead to unconsciousness.

Scientists from the University of Gothenburg (Gothenburg, Sweden) and their colleagues included in a study included children and adults with a diagnosis of diabetes for five or less years when first recorded in the registries. Endpoints of retinopathy were classified as any retinopathy, preproliferative diabetic retinopathy or worse, and proliferative diabetic retinopathy. Any retinopathy included any signs of retinopathy.

Microalbuminuria was defined as two positive test results from three samples taken within one year, with an albumin:creatinine ratio of 3-30 mg/mmol or urinary albumin of 20-200 µg/min (20-300 mg/L), and macroalbuminuria as an albumin:creatinine ratio >30 mg/mmol or urinary albumin >200 µg/min (>300 mg/L). Laboratory methods at participating care units for analyzing HbA1c level and albuminuria are regularly checked with central reference samples of HbA1c and albuminuria to ensure high accuracy. The team evaluated HbA1c as a categorical variable (<6.5% (<48 mmol/mol), 6.5-6.9 (48-52 mmol/mol), 7.0-7.4% (53-57 mmol/mol), 7.5-8.6% (58-70 mmol/mol), and >8.6% (>70 mmol/mol) and estimated risk of complications in relation to HbA1c level as a continuous variable for each 1% (10 mmol/mol).

The scientists reported that the mean age of participants was 14.7 years (43.4% female), mean duration of diabetes was 1.3 years, and mean HbA1c level was 8.0% (63.4 mmol/mol). Compared with HbA1c levels 6.5-6.9%, HbA1c levels 7.0-7.4% (53-57 mmol/mol) were associated with an increased risk of any retinopathy (1.31, 1.05 to 1.64) and microalbuminuria (1.55, 1.03 to 2.32). In Sweden, the target HbA1c value in people with type 1 diabetes is 52 mmol/mol or below, and 47 or lower in children. Elsewhere in the world, the guidelines range from 48 to 58 mmol/mol, and are often higher in children than in adults.

The authors concluded that the risk of retinopathy and nephropathy did not differ at HbA1c levels <6.5% but increased for severe hypoglycemia compared with HbA1c levels 6.5-6.9%. The risk for severe complications mainly occurred at HbA1c levels >8.6%, but for milder complications was increased at HbA1c levels >7.0%.

Marcus Lind, MD, PhD, a Professor of Diabetology and first author of the study, said, “We were unable to see that fewer instances of organ damage occurred at these lower levels. As for loss of consciousness and cramp, which are unusual, low blood glucose caused a 30% rise in risk. Patients with low HbA1c need to make sure they do not have excessively low glucose levels, fluctuations or efforts in managing their diabetes.” The study was published on August 28, 2019, in the journal BMJ.

Related Links:
University of Gothenburg


Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Drug Test Kit
DrugCheck 3000
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.